Successful long-term terbinafine therapy in an asthmatic patient with Aspergillus sensitization and bronchiectasis
Severe asthma with fungal sensitization (SAFS) is estimated to affect ~25% of patients with poorly controlled asthma. Tri-azole therapy is effective in only 60–80% and side effects are common. We report a 25 years-old woman with severe asthma, Aspergillus sensitization and marked bronchiectasis that...
Main Authors: | Isabel Rodriguez-Goncer, Rob Niven, David W. Denning |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Medical Mycology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211753917300155 |
Similar Items
-
Sensitization to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD
by: Everaerts S, et al.
Published: (2017-08-01) -
Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis
by: Ravishankar Chandrasekaran, et al.
Published: (2018-05-01) -
Terbinafine and Neutropenia
by: İrfan Yavasoğlu
Published: (2015-05-01) -
Asthma-Like Features and Anti-Asthmatic Drug Prescription in Children with Non-CF Bronchiectasis
by: Konstantinos Douros, et al.
Published: (2020-12-01) -
Clinical <i>Aspergillus</i> Signatures in COPD and Bronchiectasis
by: Pei Yee Tiew, et al.
Published: (2022-05-01)